VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $382,358 | $238,284 | $132,360 | $314,322 |
| - Cash | $221,416 | $142,144 | $102,707 | $144,610 |
| + Debt | $10,462 | $221 | $292 | $99 |
| Enterprise Value | $171,404 | $96,361 | $29,945 | $169,811 |
| Revenue | $676 | $26,665 | $0 | $0 |
| % Growth | -97.5% | – | – | – |
| Gross Profit | $676 | $26,665 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$28,641 | -$51,207 | -$43,396 | -$43,396 |
| % Margin | -4,236.8% | -192% | – | – |
| Net Income | -$28,478 | -$65,257 | -$43,505 | -$43,505 |
| % Margin | -4,212.8% | -244.7% | – | – |
| EPS Diluted | -0.65 | -1.47 | -1.62 | -1.62 |
| % Growth | 55.8% | 9.3% | 0% | – |
| Operating Cash Flow | $54,104 | -$110,363 | -$36,070 | -$36,070 |
| Capital Expenditures | $43 | -$117 | -$29 | -$29 |
| Free Cash Flow | $54,147 | -$110,480 | -$36,098 | -$36,098 |